Invention Grant
US07897612B2 Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors
失效
用作脯氨酰羟化酶抑制剂的取代的1,8-萘啶甲酰胺
- Patent Title: Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors
- Patent Title (中): 用作脯氨酰羟化酶抑制剂的取代的1,8-萘啶甲酰胺
-
Application No.: US12281677Application Date: 2007-03-06
-
Publication No.: US07897612B2Publication Date: 2011-03-01
- Inventor: Duke M. Fitch , Mariela Colón
- Applicant: Duke M. Fitch , Mariela Colón
- Applicant Address: US PA Philadelphia
- Assignee: Glaxosmithkline, LLC
- Current Assignee: Glaxosmithkline, LLC
- Current Assignee Address: US PA Philadelphia
- Agent Tony W. Peng; Edward R. Gimmi; Charles M. Kinzig
- International Application: PCT/US2007/063359 WO 20070306
- International Announcement: WO2007/103905 WO 20070913
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Public/Granted literature
- US20090082357A1 Prolyl Hydroxylase Inhibitors Public/Granted day:2009-03-26
Information query
